Company · CIK 0001582313
Xenon Pharmaceuticals Inc.
XENESearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$36.44+$0.28 (+0.774%)
XENE · Last trade
- Prev close
- $36.16
- Range (29d)
- $36.16 – $58.80
On the record
Recent filings
- 144XENEXenon Pharmaceuticals Inc.0001950047-26-008816 · 5.0 KBSEC(opens sec.gov)
- 144XENEXenon Pharmaceuticals Inc.0001193125-26-349336 · 5.2 KBSEC(opens sec.gov)
- SCHEDULE 13G/AXENEXenon Pharmaceuticals Inc.0000902219-26-000248 · 15.4 KBSEC(opens sec.gov)
- SCHEDULE 13G/AXENEXenon Pharmaceuticals Inc.0000315066-26-002245 · 11.7 KBSEC(opens sec.gov)
- 10-QXENEQuarterly update0001193125-26-338244 · 10.2 MBSEC(opens sec.gov)
- 8-KXENECurrent report0001193125-26-338019 · 464.4 KBSEC(opens sec.gov)
- SCHEDULE 13G/AXENEXenon Pharmaceuticals Inc.0000315066-26-002171 · 11.7 KBSEC(opens sec.gov)
- 8-KXENECurrent report0001193125-26-255396 · 971.2 KBSEC(opens sec.gov)
- 10-QXENEQuarterly update0001193125-26-212153 · 8.9 MBSEC(opens sec.gov)
- 8-KXENECurrent report0001193125-26-211843 · 380.2 KBSEC(opens sec.gov)
Insiders
- AULIN SHERRYChief Financial Officer
- AYCARDI-FONSECA ERNESTOCMO
- AZAB MOHAMMADDirector
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- Bridger GaryEVP, Research & Development
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Cannon GillianDirector
Tickers
Addresses
business
200 - 3650 GILMORE WAY
BURNABY
mailing
200 - 3650 GILMORE WAY
BURNABY
Same industry